Last reviewed · How we verify
Placebo skin patch and placebo tablets — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Placebo skin patch and placebo tablets (Placebo skin patch and placebo tablets) — National Institute of Mental Health (NIMH). A placebo produces therapeutic effects through patient expectation and the psychobiological placebo response, with no active pharmacological mechanism.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Placebo skin patch and placebo tablets TARGET | Placebo skin patch and placebo tablets | National Institute of Mental Health (NIMH) | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Placebo skin patch and placebo tablets CI watch — RSS
- Placebo skin patch and placebo tablets CI watch — Atom
- Placebo skin patch and placebo tablets CI watch — JSON
- Placebo skin patch and placebo tablets alone — RSS
Cite this brief
Drug Landscape (2026). Placebo skin patch and placebo tablets — Competitive Intelligence Brief. https://druglandscape.com/ci/placebo-skin-patch-and-placebo-tablets. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab